Oscar Health (NYSE:OSCR) Trading 4% Higher

Oscar Health, Inc. (NYSE:OSCR) traded up 4% during trading on Monday . The company traded as high as $16.70 and last traded at $16.45. 98,474 shares were traded during mid-day trading, a decline of 97% from the average session volume of 3,284,804 shares. The stock had previously closed at $15.82.

Wall Street Analyst Weigh In

A number of equities research analysts have commented on the company. The Goldman Sachs Group upped their price target on Oscar Health from $16.00 to $21.00 and gave the company a “neutral” rating in a research report on Thursday, May 9th. Wells Fargo & Company upped their price target on Oscar Health from $24.00 to $27.00 and gave the company an “overweight” rating in a research report on Wednesday, June 12th. Baird R W upgraded Oscar Health to a “strong-buy” rating in a research report on Thursday, May 30th. Piper Sandler reissued an “overweight” rating and issued a $25.00 price objective on shares of Oscar Health in a research note on Wednesday, July 10th. Finally, Bank of America reissued a “neutral” rating and issued a $21.00 price objective (down from $25.00) on shares of Oscar Health in a research note on Thursday, May 30th. Three equities research analysts have rated the stock with a hold rating, five have assigned a buy rating and one has issued a strong buy rating to the company’s stock. According to data from MarketBeat, the company has an average rating of “Moderate Buy” and a consensus price target of $19.75.

Oscar Health Trading Up 6.8 %

The business has a 50 day moving average of $18.10 and a two-hundred day moving average of $16.44. The company has a debt-to-equity ratio of 0.29, a quick ratio of 1.10 and a current ratio of 1.10. The firm has a market capitalization of $4.01 billion, a price-to-earnings ratio of -41.67 and a beta of 1.62.

Oscar Health (NYSE:OSCR) last posted its quarterly earnings results on Tuesday, May 7th. The company reported $0.62 earnings per share for the quarter, topping analysts’ consensus estimates of $0.28 by $0.34. Oscar Health had a negative return on equity of 5.77% and a negative net margin of 0.82%. The business had revenue of $2.14 billion for the quarter, compared to the consensus estimate of $1.99 billion. During the same period in the prior year, the business earned ($0.18) EPS. The firm’s revenue for the quarter was up 45.8% on a year-over-year basis. Equities analysts predict that Oscar Health, Inc. will post -0.06 EPS for the current year.

Insider Buying and Selling

In related news, COO Steven Wolin sold 18,607 shares of the company’s stock in a transaction that occurred on Monday, June 3rd. The stock was sold at an average price of $19.46, for a total transaction of $362,092.22. Following the transaction, the chief operating officer now directly owns 65,316 shares of the company’s stock, valued at approximately $1,271,049.36. The transaction was disclosed in a document filed with the SEC, which can be accessed through this link. In other news, COO Steven Wolin sold 18,607 shares of the stock in a transaction that occurred on Monday, June 3rd. The stock was sold at an average price of $19.46, for a total value of $362,092.22. Following the completion of the sale, the chief operating officer now directly owns 65,316 shares of the company’s stock, valued at $1,271,049.36. The sale was disclosed in a document filed with the SEC, which is accessible through the SEC website. Also, insider Mario Schlosser sold 5,808 shares of the stock in a transaction that occurred on Monday, June 3rd. The stock was sold at an average price of $19.46, for a total value of $113,023.68. Following the completion of the sale, the insider now directly owns 65,920 shares of the company’s stock, valued at $1,282,803.20. The disclosure for this sale can be found here. In the last three months, insiders have sold 81,655 shares of company stock valued at $1,589,006. 25.11% of the stock is owned by company insiders.

Hedge Funds Weigh In On Oscar Health

Several institutional investors have recently modified their holdings of the business. Panagora Asset Management Inc. grew its holdings in shares of Oscar Health by 15.1% in the second quarter. Panagora Asset Management Inc. now owns 254,780 shares of the company’s stock valued at $4,031,000 after acquiring an additional 33,508 shares in the last quarter. Zurcher Kantonalbank Zurich Cantonalbank grew its holdings in Oscar Health by 26.9% during the second quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 24,210 shares of the company’s stock valued at $383,000 after purchasing an additional 5,138 shares during the period. Bank of New York Mellon Corp grew its holdings in Oscar Health by 161.4% during the second quarter. Bank of New York Mellon Corp now owns 1,393,048 shares of the company’s stock valued at $22,038,000 after purchasing an additional 860,226 shares during the period. Catalyst Capital Advisors LLC bought a new position in Oscar Health during the second quarter valued at $1,535,000. Finally, Hennessy Advisors Inc. bought a new position in Oscar Health during the second quarter valued at $9,047,000. 75.70% of the stock is owned by institutional investors.

Oscar Health Company Profile

Oscar Health, Inc operates as a health insurance in the United States. The company offers health plans in individual and small group markets, as well as +Oscar, a technology driven platform that help providers and payors directly enable their shift to value-based care. It also provides reinsurance products.